Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Tonix PharmaceuticalsProcessa PharmaceuticalsNovus TherapeuticsPivot PharmaceuticalsInternational Stem Cell
SymbolNASDAQ:TNXPOTCMKTS:PCSANASDAQ:NVUSOTCMKTS:PVOTFOTCMKTS:ISCO
Price Information
Current Price$1.08$9.75$0.56$0.07$0.60
52 Week RangeBuyN/ABuyN/AN/A
Analyst Ratings
Consensus RecommendationBuyN/ABuyN/AN/A
Consensus Price Target$1.30N/A$6.00N/AN/A
% Upside from Price Target20.37% upsideN/A971.81% upsideN/AN/A
Trade Information
Market Cap$14.70 million$53.49 million$7.39 millionN/A$5.96 million
Beta1.08-0.252.84N/A0.77
Average Volume14,602,72682246,118N/A3,391
Sales & Book Value
Annual RevenueN/AN/AN/AN/A$11.09 million
Price / SalesN/AN/AN/AN/A0.41
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$72.79 per share$1.76 per share$1.54 per share$0.03 per share$0.37 per share
Price / BookN/AN/AN/AN/A1.62
Profitability
Net Income$-26,090,000.00$-3,770,000.00$-14,060,000.00$-7,010,000.00N/A
EPS($268.10)N/A($1.56)N/A($0.33)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/A∞N/A∞N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/A-19.28%
Return on Equity (ROE)-171.46%-34.21%-122.39%-132.91%-177.87%
Return on Assets (ROA)-149.41%-26.38%-103.06%-96.81%-20.54%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.01%N/A0.01%N/AN/A
Current Ratio4.88%2.48%7.40%10.79%0.88%
Quick Ratio4.88%2.48%7.40%10.79%0.50%
Ownership Information
Institutional Ownership Percentage4.25%N/A37.58%N/AN/A
Insider Ownership Percentage0.40%50.05%5.70%34.77%83.16%
Miscellaneous
Employees1215N/AN/A42
Shares Outstanding8.50 million5.49 million12.97 million88.68 million7.54 million
Next Earnings Date3/16/2020 (Estimated)3/26/2020 (Estimated)3/26/2020 (Estimated)5/1/2020 (Estimated)4/20/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel